News
Overview A small university in a pretty cathedral city, Winchester was founded in 1840 as the Diocesan Training School for ...
Overview Our University of the Year for Teaching Excellence, Chichester offers its 5,000 undergraduates a more personal ...
Q2 2025 Earnings Call Transcript August 11, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...
YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1 Pivotal Phase 3 CYPRESS study enrollment on track to complete ...
Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 ...
SOUTH SAN FRANCISCO, CA, USA I August 12, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...
Patients with severely disturbed sleep had the highest comorbidity burden, lowest ejection fraction, and poorest cognitive ...
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026Announced positive data from Phase 1b/2a RESOLVE supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results